Does VALSARTAN Cause Neutrophil count increased? 56 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 56 reports of Neutrophil count increased have been filed in association with VALSARTAN (valsartan). This represents 0.3% of all adverse event reports for VALSARTAN.
56
Reports of Neutrophil count increased with VALSARTAN
0.3%
of all VALSARTAN reports
0
Deaths
54
Hospitalizations
How Dangerous Is Neutrophil count increased From VALSARTAN?
Of the 56 reports, 54 (96.4%) required hospitalization, and 9 (16.1%) were considered life-threatening.
Is Neutrophil count increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VALSARTAN. However, 56 reports have been filed with the FAERS database.
What Other Side Effects Does VALSARTAN Cause?
Drug ineffective (1,845)
Blood pressure increased (1,682)
Dizziness (1,527)
Headache (1,361)
Hypertension (1,341)
Acute kidney injury (1,301)
Dyspnoea (1,239)
Fatigue (1,156)
Malaise (1,139)
Hypotension (1,032)
What Other Drugs Cause Neutrophil count increased?
CLOZAPINE (3,125)
PREDNISONE (365)
RITUXIMAB (346)
CLOZARIL (224)
OLANZAPINE (220)
METHYLPREDNISOLONE (202)
CYCLOPHOSPHAMIDE (177)
ADALIMUMAB (175)
ALEMTUZUMAB (171)
PACLITAXEL (159)
Which VALSARTAN Alternatives Have Lower Neutrophil count increased Risk?
VALSARTAN vs VALTREX
VALSARTAN vs VAMOROLONE
VALSARTAN vs VANCOMYCIN
VALSARTAN vs VANDETANIB
VALSARTAN vs VARDENAFIL